Ray Dalio's LGND Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 1,288 shares of Ligand Pharmaceuticals Incorporated (LGND) worth $228,156, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in LGND, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Ligand Pharmaceuticals Incorporated (LGND) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ligand Pharmaceuticals Incorporated (LGND) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +1,288 | New Buy | 1,288 | $177.14 |
Ray Dalio's Ligand Pharmaceuticals Incorporated Investment FAQs
Ray Dalio first purchased Ligand Pharmaceuticals Incorporated (LGND) in Q3 2025, acquiring 1,288 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Ligand Pharmaceuticals Incorporated (LGND) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Ligand Pharmaceuticals Incorporated (LGND) was in Q3 2025, adding 1,288 shares worth $228,156. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 1,288 shares of Ligand Pharmaceuticals Incorporated (LGND), valued at approximately $228,156. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Ligand Pharmaceuticals Incorporated (LGND) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Ligand Pharmaceuticals Incorporated (LGND) was 1,288 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.